Allergies News and Research

Latest Allergies News and Research

Duke awarded $52.8M federal grant to oversee external quality assurance programs for HIV/AIDS labs

The National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), has awarded Duke University Medical Center up to $52.8 million over the next seven years to support the development, implementation and oversight of external quality assurance programs that monitor laboratories involved in HIV/AIDS research and vaccine trials around the world.

17 Nov 2010

Food allergies may lead to 'kissing' allergies

Even brushing your teeth or waiting hours after eating may not prevent some partners of people with food and medicine allergies from triggering an allergic reaction through a kiss, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov.11-16.

17 Nov 2010

Maine has most improved health care quality; Kansas needs more dentists

Maine Public Broadcasting Network News: "Nationwide, Maine is most improved when it comes to health care quality, according to 2009 statistics from the federal Agency for Healthcare Research and Quality. In one year, Maine jumped from 12th place to fourth best in categories ranging from cancer to patient safety, from maternal and child health to long-term care.

17 Nov 2010

Stratatech receives SBIR grant to develop anti-infective living human skin substitute

Stratatech Corp., a privately-held regenerative medicine company, today announced that it has been awarded a $3.5 million Fast-Track SBIR grant to expand the development of its anti-infective living human skin substitute.

17 Nov 2010

Changes to flexible spending accounts; High co-pays prompt abandoned prescriptions

Minnesota Public Radio: "[T]he federal health care reform law is cutting back on what [flexible spending] accounts will cover and how much workers can put into them. … These two changes are designed to raise more tax revenue to help pay for insuring another 32 million Americans beginning in 2014.

16 Nov 2010

FDA grants Impax final approval for generic Allegra-D ANDA

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.

16 Nov 2010

Study finds IgE antibody levels double with increasing age

In the first such study since the 1970s, researchers observed a highly statistically significant increase of IgE, a type of antibody associated with allergic reactions.

16 Nov 2010

Study finds two-thirds of asthma patients take combined ICS/LABA treatment

Despite national guidelines recommending that inhaled corticosteroid (ICS) be used alone as the preferred treatment for patients with mild persistent asthma, a new study finds that nearly two-thirds of these patients are taking more costly drugs that combine an ICS and a long-acting beta agonist (LABA) with no apparent additional clinical benefit noted based on pharmacy and medical claims.

16 Nov 2010

National campaign to highlight significance of antibiotic resistance

Antibiotic resistance is one of the world's most pressing public health threats. To bring attention to this increasing problem, the Centers for Disease Control and Prevention and other government partners will observe its third annual Get Smart About Antibiotics Week on Nov. 15-21, 2010.

16 Nov 2010

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, say allergists

Millions of Americans suffer unnecessarily with itchy, gritty, watery eyes, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology in Phoenix, Nov. 11-16. The underdiagnosis, undertreatment and self-treatment of eye allergies may seriously diminish quality of life, allergists say.

16 Nov 2010

ViroPharma presents data on Cinryze C1 esterase inhibitor for HAE at ACAAI Meeting

ViroPharma Incorporated today announced data in four poster presentations and two oral presentations relating to Cinryze (C1 esterase inhibitor [human]) at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI), November 11 through 16 in Phoenix, Ariz.

16 Nov 2010

Teva presents QNAZE Phase III study results for SAR at ACAAI Meeting

Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR), that demonstrated significantly greater symptom relief compared with placebo.

15 Nov 2010

50% of nut allergic patients not able to recognize nut types

Only half of people with peanut or tree nut allergies know what the nut they are allergic to looks like, according to a study presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix Nov. 11-16. Researchers assembled a nut display that held peanuts and nine tree nuts in 19 different forms. A worksheet, which listed the items, was completed by 1,105 participants 6 years or older. Responses were analyzed based on demographics, presence or absence of food allergies, and occupational history.

15 Nov 2010

Study finds asthma care inferior

Researchers assessed asthma burden and treatment practice in the U.S. based on results of the recently completed Asthma Insight and Management telephone survey in a new study presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix, Nov. 11-16.

15 Nov 2010

Bronchial thermoplasty helps asthma patients stop taking LABAs

If you have severe persistent asthma, bronchial thermoplasty (BT) may help you stop taking long-acting beta2-agonists (LABAs) according to a new study presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix, Nov. 11-16. This novel procedure delivers thermal energy to the airway wall to reduce airway constriction.

15 Nov 2010

Study finds obesity and super obesity associated with increased risk of asthma

Asthma is reaching epidemic levels in the U.S., with 8 percent of the total population and 10 percent of the African-American population suffering from this disease. Obesity rates are also increasing, now affecting 34 percent of the population.

15 Nov 2010

Prolonged use of cell phone increases nickel allergy

Chatting endlessly on your cell phone can lead to an allergic reaction to the nickel in your phone, according to allergists at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16. From cosmetics to jewelry, body piercings to tattoos, allergies can lurk in unlikely places, allergists say.

15 Nov 2010

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2010.

15 Nov 2010

Researchers find influenza vaccines can contain allergenic components

People with egg or gelatin allergies shouldn't assume that just because they've had a flu shot safely in the past they will be able to again, according to a new study, presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix Nov. 11-16.

15 Nov 2010

ICS/LABA combination therapy increases asthma-related pharmacy cost

Researchers find inhaled corticosteroid and long-acting beta agonist (ICS/LABA) combination products are commonly used by patients with mild asthma, despite the lack of evidence or guidelines for such use.

15 Nov 2010